Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Endothelial MICU1 protects against vascular inflammation and atherosclerosis by inhibiting mitochondrial calcium uptake
Lu Sun, … , Suowen Xu, Jianping Weng
Lu Sun, … , Suowen Xu, Jianping Weng
Published April 1, 2025
Citation Information: J Clin Invest. 2025;135(7):e181928. https://doi.org/10.1172/JCI181928.
View: Text | PDF
Research Article Cell biology Vascular biology

Endothelial MICU1 protects against vascular inflammation and atherosclerosis by inhibiting mitochondrial calcium uptake

  • Text
  • PDF
Abstract

Mitochondrial dysfunction fuels vascular inflammation and atherosclerosis. Mitochondrial calcium uptake 1 (MICU1) maintains mitochondrial Ca2+ homeostasis. However, the role of MICU1 in vascular inflammation and atherosclerosis remains unknown. Here, we report that endothelial MICU1 prevents vascular inflammation and atherosclerosis by maintaining mitochondrial homeostasis. We observed that vascular inflammation was aggravated in endothelial cell–specific Micu1 knockout mice (Micu1ECKO) and attenuated in endothelial cell–specific Micu1 transgenic mice (Micu1ECTg). Furthermore, hypercholesterolemic Micu1ECKO mice also showed accelerated development of atherosclerosis, while Micu1ECTg mice were protected against atherosclerosis. Mechanistically, MICU1 depletion increased mitochondrial Ca2+ influx, thereby decreasing the expression of the mitochondrial deacetylase sirtuin 3 (SIRT3) and the ensuing deacetylation of superoxide dismutase 2 (SOD2), leading to the burst of mitochondrial reactive oxygen species (mROS). Of clinical relevance, we observed decreased MICU1 expression in the endothelial layer covering human atherosclerotic plaques and in human aortic endothelial cells exposed to serum from patients with coronary artery diseases (CAD). Two-sample Wald ratio Mendelian randomization further revealed that increased expression of MICU1 was associated with decreased risk of CAD and coronary artery bypass grafting (CABG). Our findings support MICU1 as an endogenous endothelial resilience factor that protects against vascular inflammation and atherosclerosis by maintaining mitochondrial Ca2+ homeostasis.

Authors

Lu Sun, Ruixue Leng, Monan Liu, Meiming Su, Qingze He, Zhidan Zhang, Zhenghong Liu, Zhihua Wang, Hui Jiang, Li Wang, Shuai Guo, Yiming Xu, Yuqing Huo, Clint L. Miller, Maciej Banach, Yu Huang, Paul C. Evans, Jaroslav Pelisek, Giovanni G. Camici, Bradford C. Berk, Stefan Offermanns, Junbo Ge, Suowen Xu, Jianping Weng

×

Figure 5

MICU1 regulates EC inflammation via [Ca2+]m and SIRT3/SOD2 pathway.

Options: View larger image (or click on image) Download as PowerPoint
MICU1 regulates EC inflammation via [Ca2+]m and SIRT3/SOD2 pathway.
(A) ...
(A) Protein expression of VCAM1 was determined by immunoblot in HAECs. Cells were treated with siNC or siMICU1 and then exposed to TNF-α (10 ng/ml) for 6 hours (n = 6). (B) Protein expression of VCAM1 was determined by immunoblot in HAECs. Cells were treated with Ad-NC or Ad-MICU1 and then exposed to TNF-α (10 ng/ml) for 6 hours (n = 6). (C and D) Protein expression of SIRT3 and Ac-SOD2 were determined by immunoblot after MICU1 silencing in HAECs in the presence or absence of TNF-α (10 ng/ml) for 6 hours (n = 6). (E and F) Protein expression of SIRT3 and Ac-SOD2 were determined by immunoblot after MICU1 overexpression in HAECs in the presence or absence of TNF-α (10 ng/ml) for 6 hours (n = 6). (G) Protein expression of SIRT3, Ac-SOD2, and VCAM1 in HAECs was determined by immunoblot with SIRT3 silencing and MICU1 overexpression concurrently. Cells were exposed to TNF-α (10 ng/ml) for 6 hours (n = 5). (H) Representative images showing MitoSOX fluorescence in HAECs transfected with siNC or siMICU1 and then exposed to TNF-α (10 ng/ml). MitoTEMPO (5 μM) was added for 1 hour (n = 5). (I) Representative images showing MitoSOX fluorescence in HAECs with SIRT3 silencing or MICU1 overexpression or SIRT3 silencing and MICU1 overexpression concurrently and then exposed to TNF-α (10 ng/ml) (n = 6). Scale bars: 20 μm. Statistical analysis was performed by 1-way ANOVA followed by Bonferroni’s post hoc tests (H) and Kruskal-Wallis test followed by Dunn’s multiple-comparisons test (I).

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts